US President George Bush has called for legislation to enable the US Food and Drug Administration (FDA) to approve generic versions of biologic (typically protein-based) drugs (see also Chemistry World, January 2008, p16). But a key lawmaker, Representative John Dingell, chairman of the House Energy and Commerce Committee, has said ...